[Demonstration of denitrifying bacteria by means of sodium naphthionate.]

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Abstract Text:

H J WALTHER,

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Publishing Authors By Initials

HJ WALTHER,

For similar bacteria research abstracts see: bacteria research

PUBMED ID PMID:

MEDLINE DATE:

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zentralblatt für Bakteriologie, Parasitenkunde, In

VOLUME: 167

Page Numbers: 238-42

Journal Abbreviation:

ISSN: 0372-8110

DAY: 24

MONTH: Nov

YEAR: 1956

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 337744

[Demonstration of denitrifying bacteria by means of sodium naphthionate.] Keywords Mesh Terms:

KEYWORDS: Bacteria

MESH TERMS:

Chemical & Substance for Abstract: [Demonstration of denitrifying bacteria by means of sodium naphthionate.] Information

Substance Name: naphthalene

Registry Number: 91-20-3

Grant and Affiliation Information for [Demonstration of denitrifying bacteria by means of sodium naphthionate.]

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zentralbl Bakteriol [Orig]

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Demonstration of denitrifying bacteria by means of sodium naphthionate Related Publications

• 15-Lipoxygenase-2 is differentially expressed in normal and neoplastic ovary.
• Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling.
• Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function.
• Generation of near-Fourier-transform-limited high-energy pulses in a chain of fiber-bulk amplifiers.
• Marinesco Sjögren syndrome with rhabdomyolysis. A new subtype of the disease.
• Microcirculatory endothelial dysfunction during endotoxemia - insights into pathophysiology, pathologic mechanisms and clinical relevance.
• Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
• Postnatal management of fetal and neonatal alloimmune thrombocytopenia: the role of matched platelet transfusion and IVIG.
• Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
• Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
• Treatment of pneumonias in children with a single massive dose of sulfathiazole.
• Tumor Necrosis Factor Alpha Induces the Expression of the Nuclear Protein p8 via a Novel NFkappaB Binding Site within the Promoter.
• What does it take to control malaria?
• [Anticoagulants and fibrinolytics in pregnancy]
• [Chemical demonstration of denitrifying bacteria. Part III.]
• [Contributions to Leptospira cultivation. II. The influence of hemoglobin on the growth of pathogenic Leptospira. (With an observation on making blood cultures)]
• [Demonstration of denitrifying bacteria by means of sodium naphthionate.]
• [Establishing a protein signature from prostate tissue biopsies]
• [Intra-individual comparison of the long term effect of Non-Ovlon on caffeine pharmacokinetics]
• [Intratumoral carcinoma therapy with male hormone.]
• [Megaphen & verophen in gynecological practice.]
• [Need for blood level-oriented therapy with antiepileptic drugs in pregnancy]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [Pharmacokinetics of anticonvulsants in the perinatal period]
• [The ecbolic effect of antihistaminic substances.]
• [Time course of inhibition of caffeine elimination in response to the oral depot contraceptive agent Deposiston. Hormonal contraceptives and caffeine elimination]